Blood Genome-Wide Transcriptional Profiles of HER2 Negative Breast Cancers Patients

Table 4

Relative expression of PTSG2, TREM1, IL-8, and AGREG assessed by qRT-PCR in BC, ER−PR−HER2−, and ER+PR+HER2− samples. Statistical significance was assessed using one-way ANOVA followed by Tukey’s post hoc test.

	BC versus CTR		ER−PR−HER2− versus CTR		ER+PR+HER2− versus CTR
	FR	value	FR	value	FR	value
PTGS2	11.36	<0.0001	11.21	<0.0001	11.50	<0.0001
TREM 1	1.88	0.005	1.93	0.013	1.83	0.043
IL-8	6.99	<0.0001	5.98	<0.0001	7.94	<0.0001
AREG	4.16	<0.0001	4.07	<0.0001	4.26	<0.0001